Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Satsuma Pharmaceuticals, Inc. (STSA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| SAMLYN CAPITAL, LLC reports a 0% stake in Satsuma Pharmaceuticals, Inc. |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/08/2023 |
SC 13G/A
| BML Investment Partners, L.P. reports a 19.9% stake in Satsuma Pharmaceuticals, Inc. |
| 11/16/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/25/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| COMMODORE CAPITAL LP reports a 11.8% stake in Satsuma Pharmaceuticals, Inc. |
| 02/11/2022 |
SC 13G/A
| TPG GP A, LLC reports a 6% stake in Satsuma Pharmaceuticals, Inc. |
| 10/19/2021 |
SC 13G/A
| COMMODORE CAPITAL LP reports a 10.2% stake in Satsuma Pharmaceuticals, Inc. |
| 04/09/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/04/2020 |
SC 13G/A
| Osage University Partners III, LP reports a 0% stake in Satsuma Pharmaceuticals, Inc. |
| 10/09/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/10/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| CITADEL ADVISORS LLC reports a 5.9% stake in Satsuma Pharmaceuticals, Inc. |
| 01/27/2020 |
SC 13G/A
| WELLINGTON MANAGEMENT GROUP LLP reports a 13.5% stake in Satsuma Pharmaceuticals, Inc. |
|
|